AI developer Cortechs.ai has received approval from Health Canada for its medical imaging analysis software suite.
Cortechs.ai’s suite includes NeuroQuant and NeuroQuant MS, with automated brain segmentation and volumetric analysis, which are designed to assist in the early detection and monitoring of neurodegenerative diseases such as Alzheimer’s and multiple sclerosis, as well as the quantitative imaging analysis tool NeuroQuant Brain Tumor for evaluating brain tumor progression….
Article Source
https://www.auntminnie.com/imaging-informatics/artificial-intelligence/article/15743701/cortechsai-cortechsai-software-gets-health-canada-approval
